Association between IL-10 systemic low level and highest pain score in patients during symptomatic SARS-CoV-2 infection.
Allan J C BussmannCamila Rodrigues FerrazAline V A LimaJoão G S CastroPatrícia D RitterTiago Henrique ZaninelliTelma Saraiva-SantosWaldiceu Aparecido VerriSergio Marques BorghiPublished in: Pain practice : the official journal of World Institute of Pain (2022)
IL-10 has been described over the years as an anti-inflammatory and analgesic cytokine. The present data support that low IL-10 levels might contribute to Covid-19-associated pain.
Keyphrases
- anti inflammatory
- chronic pain
- neuropathic pain
- end stage renal disease
- pain management
- coronavirus disease
- newly diagnosed
- ejection fraction
- sars cov
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- electronic health record
- respiratory syndrome coronavirus
- big data
- machine learning
- spinal cord injury
- artificial intelligence
- patient reported